Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models ; volume:15 ; number:1 ; day:12 ; month:5 ; year:2024 ; pages:1-15 ; date:12.2024
Stem cell research & therapy ; 15, Heft 1 (12.5.2024), 1-15, 12.2024
- Creator
-
Rodríguez-Pérez, Ana I.
Garrido-Gil, Pablo
García-Garrote, Maria
Muñoz, Ana
Parga, Juan A.
Labandeira-García, Jose Luis
Rodríguez-Pallares, Jannette
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-024-03751-y
- URN
-
urn:nbn:de:101:1-2407221030581.877467519633
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rodríguez-Pérez, Ana I.
- Garrido-Gil, Pablo
- García-Garrote, Maria
- Muñoz, Ana
- Parga, Juan A.
- Labandeira-García, Jose Luis
- Rodríguez-Pallares, Jannette
- SpringerLink (Online service)
Other Objects (12)
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
The role of the brain renin-angiotensin system in Parkinson´s disease
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
Renin-angiotensin system inhibitor use and risk of Parkinson’s disease: a meta-analysis
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Anti-Gehirn-Autoantikörper und deren Bedeutung bei Morbus Parkinson : = Anti-brain-autoantibodies and their role in Parkinson's disease
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
The role of the brain renin-angiotensin system in Parkinson´s disease
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
Renin-angiotensin system inhibitor use and risk of Parkinson’s disease: a meta-analysis
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Anti-Gehirn-Autoantikörper und deren Bedeutung bei Morbus Parkinson : = Anti-brain-autoantibodies and their role in Parkinson's disease
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
The role of the brain renin-angiotensin system in Parkinson´s disease
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
Renin-angiotensin system inhibitor use and risk of Parkinson’s disease: a meta-analysis
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Anti-Gehirn-Autoantikörper und deren Bedeutung bei Morbus Parkinson : = Anti-brain-autoantibodies and their role in Parkinson's disease
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
Parkinson
Parkinson